Methods of treating cancer with an FGFR inhibitor
US11628162B2 · kind B2 · utility
4Cited by
71References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2020 |
| Grant date | Apr 18, 2023 |
| Priority date | — |
| Expiry date | Aug 30, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application relates to methods of treating cancer in a patient in need thereof, comprising administering a Fibroblast Growth Factor Receptors (FGFR) inhibitor to the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.